# Heart Biomarker Evaluation in Apnea Treatment

> **NCT01086800** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 318 (actual)

## Conditions studied

- Cardiovascular Disease
- Obstructive Sleep Apnea
- Coronary Artery Disease

## Interventions

- **OTHER:** Healthy Lifestyles and Sleep Education plus PAP
- **OTHER:** Healthy Lifestyles and Sleep Education plus Supplemental Oxygen
- **OTHER:** Healthy Lifestyles and Sleep Education

## Key facts

- **NCT ID:** NCT01086800
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-08
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2013-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086800, "Heart Biomarker Evaluation in Apnea Treatment". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT01086800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*